Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Transfection Reagent And Equipment Market Size Forecast to Reach $1.18 Billion by 2026

(PharmaNewsWire.Com, August 24, 2021 ) Transfection Reagent And Equipment Market size is forecast to reach $1.18 billion by 2026, growing at a CAGR of 7.1% during the forecast period 2021-2026. Transfection is the method of inserting genetic material into eukaryotic cells, such as DNA or RNA, to enable the cell's own machinery to produce or express proteins. By interfering with the translation mechanism, a double-stranded RNA transfection is used to halt the development of such proteins. Transfection allows researchers to examine gene regulation and expression as well as genetics.



There are various methods in transfection reagent such as biochemical, calcium phosphate, dendrimers, electroporation and others. Rising prevalence of cancer across the globe combined with increasing demand for synthetic genes are the major factors driving the growth of the market. Increasing research & development activities and enhancing healthcare infrastructure is set to further enhance the overall market development of the Transfection Reagent and Equipment Market for the period 2021-2026.



Transfection Reagent And Equipment Market Segment Analysis – By Product



Transfection Reagent held the largest share in the Transfection Reagent and Equipment Market in 2020 and is estimated to grow at a CAGR 7.5% during the forecast period 2021-2026. Transfection reagent helps to promote exogenous nucleic acids such as DNA, RNA, or oligonucleotides. The transfection reagents ensure that the transfection process is as efficient as possible by delivering the greatest number of transfected cells with the foreign gene. When transfecting a variety of cell types, the reagents are often low in toxicity. Transfection reagent helps to introduced macromolecules into cultured and primary cells by using various methods such as biochemical, calcium phosphate, dendrimers, and electroporation. Transfection Reagent are estimated to register the higher CAGR over the period 2021-2026.



Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=508500

Report Price: $ 5900 (Single User License)



Transfection Reagent And Equipment Market Segment Analysis – By Method



Calcium Phosphate held the largest share in the Transfection Reagent And Equipment Market in 2020 and is estimated to grow at a CAGR 7.9% during the forecast period 2021-2026. Calcium Phosphate is commonly used method for transfection. It is used for introduction of DNA into mammalian cells by forming a calcium phosphate-DNA precipitate. It promotes the binding of the DNA to cell surfaces. Calcium Phosphate is estimated to register the higher CAGR over the period 2021-2026.



Transfection Reagent And Equipment Market Segment Analysis – By Geography



North America dominated the Transfection Reagent And Equipment Market with a major share of 36.9% in 2020. This is attributed to increase in demand for protein therapeutics and presence of leading manufacturer also government support to promote R&D on cancer therapeutics, is also increasing the growth of the market in this region.



However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to the development of health infrastructures and increasing awareness of health care. Increasing demand for genomic technology is also increasing the growth of the market in this region.



Inquiry Before Buying @ https://www.industryarc.com/reports/request-quote?id=508500



Transfection Reagent And Equipment Market Drivers



Increasing Prevalence of Cancer



Increasing prevalence of cancer is increasing the growth of the Transfection Reagent And Equipment Market. This is attributed to the development of the technologically advanced devices with extended longevity. Some of the major factor of cancer includes unhealthy diet, usage of smoking, and physical inactivity among others which raises the blood pressure and blood glucose causing overweight and obesity. According to WHO, cancer is the leading cause of death across the globe and causes around 10 million deaths in 2020. Thus, increasing the growth of the Transfection Reagent And Equipment Market during the forecast period 2021-2026.



Technological Advancements



Technological advancements is increasing the growth of the Transfection Reagent And Equipment Market. Technological advancements has enabled the manufacturers to develop new transfection technologies. Increasing advancements such as synthetic gene. Thus, increasing the growth of the Transfection Reagent And Equipment Market during the forecast period 2021-2026.



Transfection Reagent And Equipment Market Challenges



Lack of Skilled and Trained Healthcare Professionals



Some of the factors that are set to impede the growth of the Transfection Reagent And Equipment Market are lack of skilled and trained healthcare professionals. High cost of Transfection Reagent And Equipment, lack of compensation policy, and certain limitation of transfection reagent is also set to hinder the growth of the market.



Transfection Reagent And Equipment Market Landscape



Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Transfection Reagent And Equipment Market. In 2020, the Transfection Reagent And Equipment Market share is consolidated by the top ten players present in the market. The Transfection Reagent And Equipment Market, top 10 companies are Lonza Group, Merck KGaA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., MaxCyte, Inc., Mirus Bio LLC., Promega Corporation, Horizon Discovery Ltd., Polyplus-transfection SA and F. Hoffmann-La Roche Ltd.



Key Takeaways



North America dominated the Transfection Reagent And Equipment Market in 2020 owing to the wide availability of advanced technologies and favorable reimbursement policies. The Transfection Reagent And Equipment Market scope for different regions will be provided in the final report.



Increasing healthcare expenditure and technological advancement along with the new innovations are likely to aid the market growth of the Transfection Reagent And Equipment Market report.



Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Transfection Reagent And Equipment Market report.



Lack of skilled and trained healthcare professionals and high cost of transfection reagents is poised to create the hurdles for the Transfection Reagent and Equipment Market.



Related Reports :



A. Transfection Technologies Market

https://www.industryarc.com/Research/Transfection-Technologies-Market-Research-506230



B. Cell Culture Market

https://www.industryarc.com/Report/15167/cell-culture-market.html



For more Lifesciences and Healthcare Market reports, please click here



About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

IndustryARC

Venkat Reddy

(+1) 970-236-3677

venkat@industryarc.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC